<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0002036234</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001706431</issuerCik>
            <issuerName>VIR BIOTECHNOLOGY INC</issuerName>
            <secFileNumber>001-39083</secFileNumber>
            <issuerAddress>
                <ns2:street1>1800 Owens Street Suite 900</ns2:street1>
                <ns2:city>San Francisco </ns2:city>
                <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                <ns2:zipCode>94158</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>4159064324</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>VANINA DE VERNEUIL</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>7373</noOfUnitsSold>
            <aggregateMarketValue>67094.30</aggregateMarketValue>
            <noOfUnitsOutstanding>137720120</noOfUnitsOutstanding>
            <approxSaleDate>02/26/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>02/22/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Restricted Stock Units</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>7373</amountOfSecuritiesAcquired>
            <paymentDate>02/22/2025</paymentDate>
            <natureOfPayment>N/A</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>VANINA DE VERNEUIL</name>
                <address>
                    <ns2:street1>1800 Owens Street Suite 900</ns2:street1>
                    <ns2:city>San Francisco </ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94158</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>02/24/2025</saleDate>
            <amountOfSecuritiesSold>5140</amountOfSecuritiesSold>
            <grossProceeds>48590.48</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>VANINA DE VERNEUIL</name>
                <address>
                    <ns2:street1>1800 Owens Street Suite 900</ns2:street1>
                    <ns2:city>San Francisco </ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94158</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>12/02/2024</saleDate>
            <amountOfSecuritiesSold>76</amountOfSecuritiesSold>
            <grossProceeds>624.73</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>02/26/2025</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>08/05/2024</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Vanina de Verneuil</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4734}]
144
0002036234
XXXXXXXX
LIVE
0001706431
VIR BIOTECHNOLOGY INC
001-39083
1800 Owens Street Suite 900
San Francisco
CA
94158
4159064324
VANINA DE VERNEUIL
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
7373
67094.30
137720120
02/26/2025
NASDAQ
Common
02/22/2025
Restricted Stock Units
Issuer
N
7373
02/22/2025
N/A
N
VANINA DE VERNEUIL
1800 Owens Street Suite 900
San Francisco
CA
94158
Common
02/24/2025
5140
48590.48
VANINA DE VERNEUIL
1800 Owens Street Suite 900
San Francisco
CA
94158
Common
12/02/2024
76
624.73
02/26/2025
08/05/2024
/s/ Vanina de Verneuil